(Q42473091)

1 November 2017

title

Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia (English)

1 reference

progressive supranuclear palsy

1 November 2017

0 references

frontotemporal dementia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Corticobasal syndrome

1 reference

9

1 reference

1 November 2017

Shigeki Hirano

1

1 reference

1 November 2017

Hitoshi Shinotoh

2

1 reference

1 November 2017

Hitoshi Shimada

3

1 reference

1 November 2017

Akiyo Aotsuka

4

1 reference

1 November 2017

Noriko Tanaka

5

1 reference

1 November 2017

Tsuneyoshi Ota

6

1 reference

1 November 2017

Koichi Sato

7

1 reference

1 November 2017

Hiroshi Ito

8

1 reference

1 November 2017

Kiyoshi Fukushi

10

1 reference

1 November 2017

Toshiaki Irie

11

1 reference

1 November 2017

Tetsuya Suhara

12

1 reference

1 November 2017

language of work or name

English

0 references

publication date

17 June 2010

1 reference

1 November 2017

1 reference

1 November 2017

volume

133

1 reference

1 November 2017

issue

Pt 7

1 reference

1 November 2017

page(s)

2058-2068

1 reference

Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Involvement of motor pathways in corticobasal syndrome detected by diffusion tensor tractography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Pathologic heterogeneity in clinically diagnosed corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

FDG PET in the differential diagnosis of parkinsonian disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Abnormal metabolic networks in atypical parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Donepezil in the treatment of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Signature tau neuropathology in gray and white matter of corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Failure of cholinergic agonist RS-86 to improve cognition and movement in PSP despite effects on sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Brain acetylcholinesterase activity in FTDP-17 studied by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

PET study of brain acetylcholinesterase in cerebellar degenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Frontotemporal degeneration, Pick's disease, Pick complex, and Ravel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Automated Talairach Atlas labels for functional brain mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Physostigmine treatment of progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Astasia and gait failure with damage of the pontomesencephalic locomotor region

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Neurochemical enzyme changes in Alzheimer's and Pick's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Assessment of spatial normalization of PET ligand images using ligand-specific templates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Neurochemical features of frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Corticobasal degeneration. A clinical study of 36 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

The nucleus basalis of Meynert in neurological disease: a quantitative morphological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Anterior cingulate and motor network metabolic impairment in progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Corticobasal degeneration: neuropathologic and clinical heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Altered serotonergic and cholinergic synaptic markers in Pick's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Cholinergic vesicular transporters in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

The basal nucleus of Meynert in patients with progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Decreased Cerebrospinal Fluid Acetylcholinesterase in Patients with Subcortical Ischemic Vascular Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Cholinergic systems in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Neocortical cholinergic neurons in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Magnetic resonance imaging findings in corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Apraxia in movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWQ120

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWQ120

1 reference

1 November 2017

1 reference